deeponco.bsky.social
Deep Chakrabarti
@deeponco.bsky.social
26 followers 36 following 3 posts
Locum Consultant Uro-Oncology @royalmarsdenNHS, Keen on Football/Aviation/Cats
Posts Media Videos Starter Packs
deeponco.bsky.social
Deep Chakrabarti @deeponco.bsky.social · Jul 1
@alison-tree.bsky.social @ccparker.bsky.social #prostatecancer #pcsm
scinews.bsky.social
Science News @scinews.bsky.social · Jul 1
This review discusses the contemporary management of all stages of prostate cancer, enabling holistic individualization of treatment, and describes the promise of future research to further improve outcomes.

Open Access
acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
2 3
deeponco.bsky.social
Deep Chakrabarti @deeponco.bsky.social · Jun 13
Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology

@alison-tree.bsky.social @harshanigreen.bsky.social

Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...
3 8
deeponco.bsky.social
Deep Chakrabarti @deeponco.bsky.social · May 26
Management of Testicular Cancer

@ascocancer.bsky.social

doi.org/10.1200/OP-2...
2
Reposted by Deep Chakrabarti
alison-tree.bsky.social
Alison Tree @alison-tree.bsky.social · May 23
Excited to see the HERMES trial results in print www.sciencedirect.com/science/arti...
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk
HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy
To demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.This single centre, non-comparative, pha…
www.sciencedirect.com
3 7